Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ciputra A Hartana, M.D., Ph.D.

Concepts (111)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-17202469341.370 Why?
Perforin220181681.250 Why?
HIV Seropositivity220239701.180 Why?
Urinary Bladder Neoplasms6201822290.780 Why?
HIV Infections72024166780.750 Why?
CD8-Positive T-Lymphocytes4202244380.660 Why?
Proviruses420243160.640 Why?
Transforming Growth Factor beta212018750.620 Why?
Myeloid Cells120218040.550 Why?
Intercellular Adhesion Molecule-11201811550.480 Why?
CD4-Positive T-Lymphocytes6202343790.480 Why?
Dendritic Cells2202327230.460 Why?
Immunologic Memory2202313480.430 Why?
Sentinel Lymph Node Biopsy120167010.410 Why?
Interleukin-15220231840.370 Why?
DNA Methylation2201842820.300 Why?
Flow Cytometry1201659750.270 Why?
Viral Load3202332920.260 Why?
MicroRNAs1202137310.250 Why?
Killer Cells, Natural2202321330.240 Why?
Virus Latency220243560.230 Why?
Gene Expression Regulation, Neoplastic1201884250.210 Why?
Carcinoma, Renal Cell1201631230.200 Why?
Kidney Neoplasms1201642290.180 Why?
Interferon-alpha120248950.170 Why?
Oxidative Phosphorylation120214800.170 Why?
Signal Transduction22021233870.170 Why?
Histone Deacetylase Inhibitors120247890.160 Why?
Receptors, Antigen, T-Cell, alpha-beta120228040.160 Why?
Germinal Center120203770.150 Why?
Glycolysis120218250.150 Why?
Hematoxylin12016640.140 Why?
Eosine Yellowish-(YS)12016720.140 Why?
Keratin-1812016380.140 Why?
Anti-Retroviral Agents2202317120.140 Why?
Urothelium120182770.140 Why?
Matrix Metalloproteinase 2120184720.130 Why?
Lymphocytes, Tumor-Infiltrating2201810380.130 Why?
Histocompatibility Antigens Class I1202213660.130 Why?
False Negative Reactions120165870.130 Why?
Adenoma, Oxyphilic120161430.130 Why?
T-Lymphocytes, Helper-Inducer120209860.130 Why?
Infant, Newborn22023255750.110 Why?
Antigens, Neoplasm2201919830.100 Why?
Staining and Labeling1201610990.100 Why?
Urinary Bladder1201811710.100 Why?
Cadherins120169060.100 Why?
Neoadjuvant Therapy2201827210.090 Why?
Epigenesis, Genetic2202136390.090 Why?
Alleles1202269310.090 Why?
Immunotherapy, Adoptive1201912550.090 Why?
Immunity, Innate1202229560.090 Why?
T-Lymphocyte Subsets1201818370.090 Why?
Antiviral Agents1202229780.090 Why?
Humans1720247420880.090 Why?
Lymphocyte Activation2201855190.090 Why?
Lymphatic Metastasis1201629060.080 Why?
Cells, Cultured32018192230.080 Why?
B-Lymphocytes2202046640.070 Why?
Sequence Analysis, DNA1201848010.070 Why?
Antineoplastic Combined Chemotherapy Protocols22018114720.070 Why?
Tumor Escape220193490.070 Why?
Immunotherapy2201844140.070 Why?
Phenotype12023163310.060 Why?
T-Lymphocytes, Regulatory1201829860.060 Why?
Neoplasm Proteins1201636910.060 Why?
Receptors, Interleukin-2112023330.060 Why?
Aged, 80 and over52020576830.060 Why?
Aged720201629440.050 Why?
Coronavirus Infections1202031300.050 Why?
Carcinoma, Squamous Cell1201840290.050 Why?
Pneumonia, Viral1202032360.050 Why?
Male820213495380.050 Why?
T-Lymphocytes12019101630.050 Why?
Sensitivity and Specificity12016147200.050 Why?
Female820213795920.050 Why?
Middle Aged720202131270.050 Why?
Proto-Oncogene Proteins c-bcl-6120201930.040 Why?
Cell Line, Tumor12016166650.040 Why?
Tumor Necrosis Factor-alpha2202044140.040 Why?
Prospective Studies22018531870.040 Why?
Muscle Neoplasms120181390.040 Why?
Interleukin-13120183890.030 Why?
Sweden1201813430.030 Why?
Drug Therapy120184970.030 Why?
Spleen1202023590.030 Why?
CpG Islands1201811700.030 Why?
Antigen-Presenting Cells120169690.030 Why?
Cystectomy120186820.030 Why?
Cell Survival1202358720.030 Why?
Interleukin-17120189000.030 Why?
Lymph Nodes1202334650.020 Why?
Interleukin-101201612000.020 Why?
Antigen Presentation1201612840.020 Why?
Forkhead Transcription Factors1201816130.020 Why?
Down-Regulation1201830010.020 Why?
Doxorubicin1201622150.020 Why?
Neoplasms12019215960.020 Why?
Neoplasm Invasiveness1201836120.020 Why?
Chemotherapy, Adjuvant1201834710.020 Why?
Interferon-gamma1201831990.020 Why?
Cell Lineage1201825040.020 Why?
Neoplasm Staging12018110010.010 Why?
Randomized Controlled Trials as Topic1201999410.010 Why?
Treatment Outcome22018629660.010 Why?
Cell Differentiation12018114700.010 Why?
Pandemics1202083280.010 Why?
Case-Control Studies12018217190.010 Why?
Prognosis12018290100.010 Why?
Time Factors12018400540.010 Why?
Animals120191685610.000 Why?
Hartana's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (111)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.